WHO/IGWG
Official executive summary of the report of the WHO Expert Working Group on Research and Development Financing
Submitted by thiru on 23. December 2009 - 13:5423 December 2009
The Official Executive Summary and Recommendations of the Report of the Expert Working Group on Research and Development Financing to the Executive Board has been published on the website of the WHO Executive Board as document EB126/6 Add.1. It has a provisional agenda item number of 4.3. The official WHO link to this Executive Summary is: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_6Add1-en.pdf
KEI Comments to EWG 2nd Web-based Public Hearing: Defending the Status Quo, or Roadmap for Change?
Submitted by James Love on 6. September 2009 - 6:43On Saturday, KEI filed comments with the WHO EWG's 2nd web based hearing. Our comments focused on the criteria for new proposals.
KEI comments to IGWG2
Written by Judit Rius Sanjuan
Friday, 09 November 2007
Friday, 09 November 2007
KEI comments to IGWG2
8 November 2007
KEI appreciates the opportunity to speak today. Our comments will focus on 3 items.
1. Transparency
WHO IGWG (Spanish)
Written by Judit Rius Sanjuan
Wednesday, 23 May 2007
Wednesday, 23 May 2007
Informe de KEI
Views on the IGWG
Written by James Love
Second IGWG Meeting
November 5-10, 2007
KEI Documents
November 9, 2007. Malini Aisola. Reasons Why the IGWG Should Not Place Limits on the Scope of Disease.
Comments on the IGWG II bis
Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International
Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines
Nicoletta Dentico, Policy and Advocacy Advisor, DNDi
Margaret Chan on “new initiatives, and new incentive schemes”
Submitted by thiru on 13. July 2009 - 22:00At the WIPO Conference on Intellectual Property and Public Policy Issues today, Margaret Chan, the Director General of the World Health Organization, made the following speech at WIPO’s Conference on Intellectual Property and Public Policy Issues on the topic of “Strengthening Multilateral Cooperation on IP and Public Health” where she shared the limelight with Pascal Lamy, Director General of the World Trade Organ
WHO releases sketchy report on second meeting of Expert Working Group on R&D Financing
Submitted by Staff on 30. June 2009 - 22:00The World Health Organization just published a report on this week’s second meeting of the WHO Expert Working Group (EWG) on R&D Financing.
Civil Society letter to Members of the WHO Expert Working Group on R&D Financing
Submitted by Staff on 30. June 2009 - 15:45Today nine NGOs sent a letter the WHO Expert Working Group on R&D Financing. The letter focuses on issues about transparency, conflicts of interest, and EWG outcomes. The whole EWG seems to be going very badly right now, in part because of the US government and much of Northern Europe is working hand and glove with the pharmaceutical industry, and partly because the Gates Foundation is protecting big pharma and seems to have an ideological attachment to strong IPR.
